$12.3 Million is the total value of Elefante Mark B's 107 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 11.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FISV | Buy | FISERV | $699,000 | +6.4% | 5,715 | +0.3% | 5.66% | -5.1% |
| AAPL | Sell | APPLE INC | $658,000 | +0.3% | 4,559 | -0.1% | 5.33% | -10.5% |
| MA | Buy | MASTERCARD | $597,000 | +9.5% | 4,911 | +1.4% | 4.83% | -2.2% |
| PG | Buy | PROCTER & GAMBLE | $586,000 | +6.4% | 6,715 | +9.5% | 4.74% | -5.1% |
| CB | Buy | CHUBB LIMITED | $575,000 | +20.0% | 3,950 | +12.4% | 4.66% | +7.1% |
| GOOGL | Buy | ALPHABET INC CL A | $556,000 | +12.6% | 597 | +2.4% | 4.50% | +0.4% |
| JNJ | Buy | JOHNSON & JOHNSON | $551,000 | +7.2% | 4,170 | +1.0% | 4.46% | -4.3% |
| MMM | Buy | 3M | $525,000 | +9.8% | 2,523 | +0.8% | 4.25% | -2.0% |
| CVS | Buy | CVS HEALTH | $515,000 | +3.2% | 6,400 | +0.7% | 4.17% | -7.9% |
| NVS | Buy | NOVARTIS AG ADR | $502,000 | +20.4% | 6,019 | +7.1% | 4.06% | +7.4% |
| NSRGY | Buy | NESTLE SA ADR | $501,000 | +23.4% | 5,745 | +9.0% | 4.06% | +10.1% |
| UTX | Buy | UNITED TECHNOLOGIES | $498,000 | +9.5% | 4,075 | +0.6% | 4.03% | -2.3% |
| ADP | Buy | AUTOMATIC DATA PROCESSING | $488,000 | +1.9% | 4,761 | +1.8% | 3.95% | -9.1% |
| ABT | Buy | ABBOTT LABS | $471,000 | +20.8% | 9,686 | +10.2% | 3.81% | +7.8% |
| UL | Buy | UNILEVER PLC NEW ADR | $449,000 | +26.5% | 8,295 | +14.9% | 3.64% | +12.9% |
| DHR | Buy | DANAHER CORP | $432,000 | +13.4% | 5,115 | +14.9% | 3.50% | +1.2% |
| ROK | Buy | ROCKWELL AUTOMATION | $426,000 | +5.2% | 2,630 | +1.2% | 3.45% | -6.1% |
| ATR | Buy | APTARGROUP | $421,000 | +16.0% | 4,852 | +2.9% | 3.41% | +3.5% |
| XOM | Buy | EXXON MOBIL | $394,000 | +0.8% | 4,902 | +2.9% | 3.19% | -10.1% |
| CNI | Buy | CANADIAN NATL RAILWAY | $376,000 | +14.3% | 4,642 | +4.3% | 3.04% | +2.0% |
| RHHBY | Buy | ROCHE HLDG LTD ADR | $355,000 | +9.6% | 11,135 | +9.9% | 2.87% | -2.2% |
| ADI | Buy | ANALOG DEVICES | $324,000 | +20.9% | 4,160 | +27.6% | 2.62% | +7.9% |
| XYL | Buy | XYLEM INC | $293,000 | +32.6% | 5,286 | +20.1% | 2.37% | +18.3% |
| SLB | Buy | SCHLUMBERGER | $255,000 | -14.1% | 3,855 | +1.6% | 2.06% | -23.4% |
| PEP | PEPSICO | $241,000 | +3.4% | 2,084 | 0.0% | 1.95% | -7.7% | |
| XLNX | New | XILINX | $235,000 | – | 3,660 | +100.0% | 1.90% | – |
| ILMN | Buy | ILLUMINA | $218,000 | +5.8% | 1,253 | +3.7% | 1.76% | -5.6% |
| New | NOVOZYMES A S DKK 2.0 | $211,000 | – | 4,810 | +100.0% | 1.71% | – | |
| ORCL | Exit | ORACLE | $0 | – | -5,160 | -100.0% | -2.10% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-07-26
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FISERV | 19 | Q2 2020 | 8.8% |
| MASTERCARD | 19 | Q2 2020 | 8.4% |
| APPLE INC | 19 | Q2 2020 | 8.0% |
| ALPHABET INC CL A | 19 | Q2 2020 | 7.3% |
| JOHNSON & JOHNSON | 19 | Q2 2020 | 6.5% |
| PROCTER & GAMBLE | 19 | Q2 2020 | 7.1% |
| AUTOMATIC DATA PROCESSING | 19 | Q2 2020 | 6.5% |
| ABBOTT LABS | 19 | Q2 2020 | 5.6% |
| NESTLE SA ADR | 19 | Q2 2020 | 8.0% |
| NOVARTIS AG ADR | 19 | Q2 2020 | 6.5% |
View Elefante Mark B's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-07-28 |
| 13F-HR | 2020-05-07 |
| 13F-HR | 2020-01-15 |
| 13F-HR | 2019-11-06 |
| 13F-HR | 2019-07-24 |
| 13F-HR | 2019-05-02 |
| 13F-HR | 2019-01-24 |
| 13F-HR | 2018-10-15 |
| 13F-HR | 2018-07-30 |
| 13F-HR | 2018-04-24 |
View Elefante Mark B's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.